Gorlin Syndrome patient and Trustee of the Gorlin Syndrome Group Sally Webster in the news.
Researchers have developed a new medication, a once-a-day pill called Vismodegib, which can shrink tumours and scientists have published the findings of clinical trials in the USA.
Our thanks go to Sally for agreeing to be interviewed and for raising the awareness of Gorlin Syndrome.
Researchers have developed a new medication, a once-a-day pill called Vismodegib, which can shrink tumours and scientists have published the findings of clinical trials in the USA.
Our thanks go to Sally for agreeing to be interviewed and for raising the awareness of Gorlin Syndrome.
